Long term aspirin may reduce overall cancer riskBMJ 2016; 352 doi: https://doi.org/10.1136/bmj.i1319 (Published 04 March 2016) Cite this as: BMJ 2016;352:i1319
- Jacqui Wise
Taking low dose aspirin regularly for at least six years is associated with a modest but significant reduction in the risk of cancer, especially cancer of the gastrointestinal tract, research published in JAMA Oncology has shown.1
The study found that taking aspirin at least twice a week was associated with a 3% lower incidence of developing any type of cancer. This was primarily due to a 15% lower risk of gastrointestinal tract cancers and a 19% lower risk of cancers …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial